ID   PEMT_HUMAN              Reviewed;         199 AA.
AC   Q9UBM1; A8MZ66; B4DY41; D3DXC3; Q6IAQ5; Q86VL3; Q9BW86; Q9UHY6;
AC   Q9Y6V9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 4.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=Phosphatidylethanolamine N-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216};
DE            Short=PEAMT {ECO:0000255|HAMAP-Rule:MF_03216};
DE            Short=PEMT {ECO:0000255|HAMAP-Rule:MF_03216};
DE            EC=2.1.1.17 {ECO:0000255|HAMAP-Rule:MF_03216};
DE            EC=2.1.1.71 {ECO:0000255|HAMAP-Rule:MF_03216};
DE   AltName: Full=PEMT2;
DE   AltName: Full=Phospholipid methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216};
DE            Short=PLMT {ECO:0000255|HAMAP-Rule:MF_03216};
GN   Name=PEMT {ECO:0000255|HAMAP-Rule:MF_03216}; Synonyms=PEMPT, PNMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-175.
RC   TISSUE=Liver;
RX   PubMed=9989271; DOI=10.1016/S0005-2760(98)00147-7;
RA   Walkey C.J., Shields D.J., Vance D.E.;
RT   "Identification of three novel cDNAs for human
RT   phosphatidylethanolamine N-methyltransferase and localization of the
RT   human gene on chromosome 17p11.2.";
RL   Biochim. Biophys. Acta 1436:405-412(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-175.
RX   PubMed=11420179; DOI=10.1016/S1388-1981(01)00122-6;
RA   Shields D.J., Agellon L.B., Vance D.E.;
RT   "Structure, expression profile and alternative processing of the human
RT   phosphatidylethanolamine N-methyltransferase (PEMT) gene.";
RL   Biochim. Biophys. Acta 1532:105-114(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ILE-58 AND
RP   MET-175.
RC   TISSUE=Liver;
RA   Maeda E., Watanabe M., Wang J., Kasuga M.;
RT   "Homo sapiens phosphatidylethanolamine N-methyltransferase mRNA.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hypothalamus;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ILE-58.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ILE-58 AND MET-175.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS TRP-3; ILE-58; MET-175 AND
RP   ARG-194 (ISOFORM 1), AND VARIANT ALA-11 (ISOFORM 2).
RG   NIEHS SNPs program;
RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT MET-175.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ILE-58 AND MET-175.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   TOPOLOGY.
RX   PubMed=12431977; DOI=10.1074/jbc.M210904200;
RA   Shields D.J., Lehner R., Agellon L.B., Vance D.E.;
RT   "Membrane topography of human phosphatidylethanolamine N-
RT   methyltransferase.";
RL   J. Biol. Chem. 278:2956-2962(2003).
RN   [12]
RP   MUTAGENESIS OF GLY-98; GLY-100; GLU-180 AND GLU-181.
RX   PubMed=12842883; DOI=10.1074/jbc.M306308200;
RA   Shields D.J., Altarejos J.Y., Wang X., Agellon L.B., Vance D.E.;
RT   "Molecular dissection of the S-adenosylmethionine-binding site of
RT   phosphatidylethanolamine N-methyltransferase.";
RL   J. Biol. Chem. 278:35826-35836(2003).
RN   [13]
RP   ALTERNATIVE SPLICING.
RX   PubMed=17456783; DOI=10.1096/fj.07-8227com;
RA   Resseguie M., Song J., Niculescu M.D., da Costa K.A., Randall T.A.,
RA   Zeisel S.H.;
RT   "Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression
RT   is induced by estrogen in human and mouse primary hepatocytes.";
RL   FASEB J. 21:2622-2632(2007).
RN   [14]
RP   ALTERNATIVE SPLICING, TOPOLOGY, GLYCOSYLATION (ISOFORM 2), AND
RP   SUBCELLULAR LOCATION (ISOFORMS 1 AND 2).
RX   PubMed=20860552; DOI=10.1042/BJ20100490;
RA   Morita S.Y., Takeuchi A., Kitagawa S.;
RT   "Functional analysis of two isoforms of phosphatidylethanolamine N-
RT   methyltransferase.";
RL   Biochem. J. 432:387-398(2010).
CC   -!- FUNCTION: Catalyzes the three sequential steps of the methylation
CC       pathway of phosphatidylcholine biosynthesis, the SAM-dependent
CC       methylation of phosphatidylethanolamine (PE) to
CC       phosphatidylmonomethylethanolamine (PMME), PMME to
CC       phosphatidyldimethylethanolamine (PDME), and PDME to
CC       phosphatidylcholine (PC). {ECO:0000255|HAMAP-Rule:MF_03216}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + phosphatidyl-N-
CC       methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-
CC       dimethylethanolamine. {ECO:0000255|HAMAP-Rule:MF_03216}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + phosphatidyl-N-
CC       dimethylethanolamine = S-adenosyl-L-homocysteine +
CC       phosphatidylcholine. {ECO:0000255|HAMAP-Rule:MF_03216}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine +
CC       phosphatidylethanolamine = S-adenosyl-L-homocysteine +
CC       phosphatidyl-N-methylethanolamine. {ECO:0000255|HAMAP-
CC       Rule:MF_03216}.
CC   -!- ENZYME REGULATION: The first methylation is rate-limiting.
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine
CC       biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03216}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:20860552}; Multi-pass membrane protein
CC       {ECO:0000305}. Mitochondrion membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}. Note=Found in endoplasmic
CC       reticulum where most PEMT activity is generated and in
CC       mitochondria. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:20860552}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=PEMT-S;
CC         IsoId=Q9UBM1-1; Sequence=Displayed;
CC       Name=2; Synonyms=PEMT-L;
CC         IsoId=Q9UBM1-2; Sequence=VSP_037311;
CC         Note=Much lower enzymatic activity than isoform 1. Variant in
CC         position: 11:V->A. {ECO:0000269|PubMed:20860552};
CC       Name=3;
CC         IsoId=Q9UBM1-3; Sequence=VSP_037311, VSP_046034;
CC         Note=No experimental confirmation available. Ref.5 (BAG63603)
CC         sequence is in conflict in position: 222:S->N. {ECO:0000305};
CC   -!- PTM: Isoform 2 is N-glycosylated with high-mannose
CC       oligosaccharides. {ECO:0000269|PubMed:20860552}.
CC   -!- SIMILARITY: Belongs to the class VI-like SAM-binding
CC       methyltransferase superfamily. PEMT/PEM2 methyltransferase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03216}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF14867.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pemt/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF176807; AAD53292.1; -; mRNA.
DR   EMBL; AF176806; AAD53291.1; -; mRNA.
DR   EMBL; AF294468; AAK19172.1; -; Genomic_DNA.
DR   EMBL; AF294463; AAK19172.1; JOINED; Genomic_DNA.
DR   EMBL; AF294464; AAK19172.1; JOINED; Genomic_DNA.
DR   EMBL; AF294465; AAK19172.1; JOINED; Genomic_DNA.
DR   EMBL; AF294466; AAK19172.1; JOINED; Genomic_DNA.
DR   EMBL; AF294467; AAK19172.1; JOINED; Genomic_DNA.
DR   EMBL; AB029821; BAA82407.1; -; mRNA.
DR   EMBL; AF113126; AAF14867.1; ALT_INIT; mRNA.
DR   EMBL; AK302251; BAG63603.1; -; mRNA.
DR   EMBL; CR457099; CAG33380.1; -; mRNA.
DR   EMBL; EU574003; ACB21050.1; -; Genomic_DNA.
DR   EMBL; AC020558; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471196; EAW55701.1; -; Genomic_DNA.
DR   EMBL; CH471196; EAW55702.1; -; Genomic_DNA.
DR   EMBL; BC000557; AAH00557.1; -; mRNA.
DR   EMBL; BC050593; AAH50593.1; -; mRNA.
DR   CCDS; CCDS11186.1; -. [Q9UBM1-2]
DR   CCDS; CCDS11187.1; -. [Q9UBM1-1]
DR   CCDS; CCDS58520.1; -. [Q9UBM1-3]
DR   RefSeq; NP_001254480.1; NM_001267551.1.
DR   RefSeq; NP_001254481.1; NM_001267552.1. [Q9UBM1-3]
DR   RefSeq; NP_009100.2; NM_007169.2. [Q9UBM1-1]
DR   RefSeq; NP_680477.1; NM_148172.2. [Q9UBM1-2]
DR   RefSeq; NP_680478.1; NM_148173.1. [Q9UBM1-1]
DR   UniGene; Hs.714193; -.
DR   ProteinModelPortal; Q9UBM1; -.
DR   BioGrid; 115672; 1.
DR   STRING; 9606.ENSP00000255389; -.
DR   SwissLipids; SLP:000001199; -. [Q9UBM1-1]
DR   BioMuta; PEMT; -.
DR   DMDM; 148887406; -.
DR   PaxDb; Q9UBM1; -.
DR   PeptideAtlas; Q9UBM1; -.
DR   PRIDE; Q9UBM1; -.
DR   TopDownProteomics; Q9UBM1-1; -. [Q9UBM1-1]
DR   DNASU; 10400; -.
DR   Ensembl; ENST00000255389; ENSP00000255389; ENSG00000133027. [Q9UBM1-2]
DR   Ensembl; ENST00000395781; ENSP00000379127; ENSG00000133027. [Q9UBM1-3]
DR   Ensembl; ENST00000395782; ENSP00000379128; ENSG00000133027. [Q9UBM1-1]
DR   Ensembl; ENST00000395783; ENSP00000379129; ENSG00000133027. [Q9UBM1-1]
DR   GeneID; 10400; -.
DR   KEGG; hsa:10400; -.
DR   UCSC; uc002grj.3; human. [Q9UBM1-1]
DR   CTD; 10400; -.
DR   DisGeNET; 10400; -.
DR   GeneCards; PEMT; -.
DR   HGNC; HGNC:8830; PEMT.
DR   HPA; HPA042375; -.
DR   MIM; 602391; gene.
DR   neXtProt; NX_Q9UBM1; -.
DR   OpenTargets; ENSG00000133027; -.
DR   PharmGKB; PA33175; -.
DR   eggNOG; KOG4142; Eukaryota.
DR   eggNOG; ENOG4111HY0; LUCA.
DR   GeneTree; ENSGT00390000007041; -.
DR   HOGENOM; HOG000208789; -.
DR   HOVERGEN; HBG000990; -.
DR   InParanoid; Q9UBM1; -.
DR   KO; K00551; -.
DR   OMA; TSTWALG; -.
DR   OrthoDB; EOG091G0IQ4; -.
DR   PhylomeDB; Q9UBM1; -.
DR   TreeFam; TF300198; -.
DR   BRENDA; 2.1.1.17; 2681.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   UniPathway; UPA00753; -.
DR   ChiTaRS; PEMT; human.
DR   GeneWiki; Phosphatidyl_ethanolamine_methyltransferase; -.
DR   GenomeRNAi; 10400; -.
DR   PRO; PR:Q9UBM1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000133027; -.
DR   CleanEx; HS_PEMT; -.
DR   CleanEx; HS_PNMT; -.
DR   ExpressionAtlas; Q9UBM1; baseline and differential.
DR   Genevisible; Q9UBM1; HS.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0080101; F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000773; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008429; F:phosphatidylethanolamine binding; IEA:Ensembl.
DR   GO; GO:0004608; F:phosphatidylethanolamine N-methyltransferase activity; IBA:GO_Central.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0050747; P:positive regulation of lipoprotein metabolic process; IEA:Ensembl.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0033273; P:response to vitamin; IEA:Ensembl.
DR   GO; GO:0046498; P:S-adenosylhomocysteine metabolic process; IEA:Ensembl.
DR   GO; GO:0046500; P:S-adenosylmethionine metabolic process; IEA:Ensembl.
DR   GO; GO:0006686; P:sphingomyelin biosynthetic process; IEA:Ensembl.
DR   HAMAP; MF_03216; PLMT; 1.
DR   InterPro; IPR024960; PEMT/MFAP.
DR   InterPro; IPR007318; Phopholipid_MeTrfase.
DR   PANTHER; PTHR15458; PTHR15458; 1.
DR   Pfam; PF04191; PEMT; 1.
DR   PIRSF; PIRSF005444; PEMT; 1.
DR   PROSITE; PS51599; SAM_PEMT_PEM2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Methyltransferase;
KW   Mitochondrion; Phospholipid biosynthesis; Phospholipid metabolism;
KW   Polymorphism; Reference proteome; S-adenosyl-L-methionine;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q08388}.
FT   CHAIN         2    199       Phosphatidylethanolamine N-
FT                                methyltransferase.
FT                                /FTId=PRO_0000193920.
FT   TOPO_DOM      2     12       Lumenal. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216,
FT                                ECO:0000305|PubMed:20860552}.
FT   INTRAMEM     13     33       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216,
FT                                ECO:0000305|PubMed:20860552}.
FT   TOPO_DOM     34     45       Lumenal. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216,
FT                                ECO:0000269|PubMed:12431977,
FT                                ECO:0000305|PubMed:20860552}.
FT   TRANSMEM     46     66       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216}.
FT   TOPO_DOM     67     93       Cytoplasmic. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216,
FT                                ECO:0000305|PubMed:20860552}.
FT   TRANSMEM     94    114       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216}.
FT   TOPO_DOM    115    157       Lumenal. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216,
FT                                ECO:0000269|PubMed:12431977,
FT                                ECO:0000305|PubMed:20860552}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216}.
FT   TOPO_DOM    179    199       Cytoplasmic. {ECO:0000255|HAMAP-
FT                                Rule:MF_03216,
FT                                ECO:0000269|PubMed:12431977,
FT                                ECO:0000305|PubMed:20860552}.
FT   REGION       98    100       S-adenosyl-L-methionine binding.
FT                                {ECO:0000255|HAMAP-Rule:MF_03216,
FT                                ECO:0000305|PubMed:12842883}.
FT   REGION      180    181       S-adenosyl-L-methionine binding.
FT                                {ECO:0000255|HAMAP-Rule:MF_03216,
FT                                ECO:0000305|PubMed:12842883}.
FT   VAR_SEQ       1      1       M -> MKRSGNPGAEVTNSSVAGPDCCGGLGNIDFRQADFC
FT                                VM (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037311.
FT   VAR_SEQ     156    199       MHASPTGLLLTVLVALTYIVALLYEEPFTAEIYRQKASGSH
FT                                KRS -> IPAPAGAVGSEARQPHGPAPDGAGGPHLHSGSPI
FT                                RRALHR (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046034.
FT   VARIANT       3      3       R -> W (in dbSNP:rs70959686).
FT                                /FTId=VAR_055372.
FT   VARIANT      58     58       V -> I (in dbSNP:rs897453).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.6}.
FT                                /FTId=VAR_032771.
FT   VARIANT      58     58       V -> L (in dbSNP:rs897453).
FT                                /FTId=VAR_060083.
FT   VARIANT     175    175       V -> M (in dbSNP:rs7946).
FT                                {ECO:0000269|PubMed:11420179,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9989271,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.6,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_016093.
FT   VARIANT     194    194       G -> R (in dbSNP:rs70965427).
FT                                /FTId=VAR_055373.
FT   MUTAGEN      98     98       G->E: Impairs binding to S-adenosyl-L-
FT                                methionine.
FT                                {ECO:0000269|PubMed:12842883}.
FT   MUTAGEN     100    100       G->D: Abolishes binding to S-adenosyl-L-
FT                                methionine.
FT                                {ECO:0000269|PubMed:12842883}.
FT   MUTAGEN     180    180       E->D: Abolishes binding to S-adenosyl-L-
FT                                methionine.
FT                                {ECO:0000269|PubMed:12842883}.
FT   MUTAGEN     181    181       E->D: Impairs binding to S-adenosyl-L-
FT                                methionine.
FT                                {ECO:0000269|PubMed:12842883}.
SQ   SEQUENCE   199 AA;  22134 MW;  98C07AB54B3B4E6A CRC64;
     MTRLLGYVDP LDPSFVAAVI TITFNPLYWN VVARWEHKTR KLSRAFGSPY LACYSLSVTI
     LLLNFLRSHC FTQAMLSQPR MESLDTPAAY SLGLALLGLG VVLVLSSFFA LGFAGTFLGD
     YFGILKEARV TVFPFNILDN PMYWGSTANY LGWAIMHASP TGLLLTVLVA LTYIVALLYE
     EPFTAEIYRQ KASGSHKRS
//
